丰富iPSC的研究多样性:利用人类生物库的收藏来改善种族代表性
David Gurwitz1,2, Rachel Steeg3
1Department of Human Molecular Genetics and Biochemistry, Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel.
Drug development research
|June 29, 2024
概括
利用现有的淋巴细胞细胞系 (LCL) 生物库来产生各种诱导的人类多能干细胞 (iPSC). 这种方法增强了精准医学和药物开发的基因组多样性,解决了目前iPSC资源的缺口.
科学领域:
- 生物医学研究生物医学研究
- 干细胞生物学 干细胞生物学
- 基因组学就是基因组学.
背景情况:
- 人类生物样本和细胞系的生物银行对于健康和药物开发研究至关重要.
- 诱导人类多能干细胞 (iPSCs) 对于应用研究至关重要,但其建立成本昂贵.
- 现有的淋巴细胞细胞系 (LCL) 收藏提供了一个未充分利用的资源.
研究的目的:
- 突出将现有的LCL重新编程为iPSC的潜力.
- 倡导使用多样化的LCL收藏来创建代表性的iPSC小组.
- 加强全球研究iPSC资源的基因组多样性.
主要方法:
- 使用已确定的协议 (例如,非整合性环节载体) 将人类LCL重编程为iPSC.
- 利用来自不同种族/祖先群体的已建立的生物银行LCL.
- 从这些重新编程的LCL中建立新的iPSC生物库.
主要成果:
- 可以成功地将LCL重编程为iPSC.
- 现有的LCL生物库包含了显著的种族和祖先多样性.
- 目前的iPSC生物库往往缺乏这种至关重要的多样性.
结论:
- 重编程LCL是一种可行的策略,可以生成多样化的iPSC.
- 利用LCL生物库可以创建更好地代表全球人类基因组多样性的iPSC面板.
- 这种方法将在全球范围内显著有利于精准医学和药物开发.
相关概念视频
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K


